Chelsea Eileen Li

Chelsea Eileen Li

Auto-generated profile, based on publicly available information

Chelsea Eileen Li

Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2019 in Neurosurgery
Verified
Journal Article
Closed access
AGAmitabh Gupta
Amitabh Gupta
ZXZhiyuan Xu
Zhiyuan Xu
OCOr Cohen-Inbar
Or Cohen-Inbar
MSM Harrison Snyder
M Harrison Snyder
LHLandon K Hobbs
Landon K Hobbs
JSJason P Sheehan
Jason P Sheehan
BACKGROUND: Some patients are diagnosed with asymptomatic meningioma(s) after undergoing a screening CT and MRI for minor ailments or postresection. OBJECTIVE: To help clinicians in decision making for treatment of asymptomatic meningiomas. METHODS: A single center retrospective cohort study of 117 patients with 122 tumors treated with Gamma Knife radiosurgery (GKRS; Elekta AB, Stockholm, Sweden). Patients were followed with longitudinal imaging and clinical evaluations. Tumor volumetry and developments of new signs or symptoms after GKRS were the end points in the study. RESULTS: Median patient age at GKRS was 60 yr (range 21-86 yr) with a median clinical follow-up of 53 mo (range 20-252 mo). The median pre-GKRS tumor volume was 3.6 ± 3.8 cc (±standard deviation). Tumors were treated with a median margin dose of 14 ± 2 Gy. At last follow-up, median tumor volume was 2.5 ± 3.6 cc. Radiological progression-free survival (PFS) rates were 97% and 94.4% at 5 yr and 10 yr, respectively. Clinical PFS rates were 86% and 70% at 5 yr and 10 yr, respectively. Development of neurological complications was seen in 21 (18%) patients, and 11 (52%) of them had undergone surgical resection prior to GKRS. CONCLUSION: GKRS is a reasonable treatment strategy for asymptomatic meningiomas and compares favorably to natural history studies in terms of tumor control and neurological preservation. It results in relatively low morbidity in previously untreated meningiomas and serves as an appealing alternative treatment modality for recurrent meningiomas in asymptomatic patients.

29 May 2025 in Science
Verified
Journal Article
Open access
IKIsaac Kauvar
Isaac Kauvar
EREthan B. Richman
Ethan B. Richman
TLTony X. Liu
Tony X. Liu
CLChelsea Li
Chelsea Li
SVSam Vesuna
Sam Vesuna
KDKarl Deisseroth
Karl Deisseroth
Emotional responses to sensory experience are central to the human condition in health and disease. We hypothesized that principles governing the emergence of emotion from sensation might be discoverable through their conservation across the mammalian lineage. We therefore designed a cross-species neural activity screen, applicable to humans and mice, combining precise affective behavioral measurements, clinical medication administration, and brain-wide intracranial electrophysiology. This screen revealed conserved biphasic dynamics in which emotionally salient sensory signals are swiftly broadcast throughout the brain and followed by a characteristic persistent activity pattern. Medication-based interventions that selectively blocked persistent dynamics while preserving fast broadcast selectively inhibited emotional responses in humans and mice. Mammalian emotion appears to emerge as a specifically distributed neural context, driven by persistent dynamics and shaped by a global intrinsic timescale.

1 June 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ELEric Lehrer
Eric Lehrer
MSM. Harrison Snyder
M. Harrison Snyder
BDBhargav D. Desai
Bhargav D. Desai
CLChelsea E. Li
Chelsea E. Li
ANAditya Narayan
Aditya Narayan
JSJason P. Sheehan
Jason P. Sheehan

1 October 2020 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
YHYi-Chieh Hung
Yi-Chieh Hung
NMNasser Mohammed
Nasser Mohammed
TMThomas Jose Eluvathingal Muttikkal
Thomas Jose Eluvathingal Muttikkal
KKKathryn N. Kearns
Kathryn N. Kearns
CLChelsea Eileen Li
Chelsea Eileen Li
JSJason P. Sheehan
Jason P. Sheehan
OBJECTIVE: The benefits and risks of pre–stereotactic radiosurgery (SRS) embolization have been reported in different studies. The goal of this study was to compare the long-term outcome of arteriovenous malformations (AVMs) treated with and without pre-SRS embolization.METHODS: A database including 1159 patients with AVMs who underwent SRS was reviewed. The embolized group was selected by including AVMs with pre-SRS embolization, maximal diameter > 30 mm, and estimated volume > 8 ml. The nonembolized group was defined as AVMs treated by SRS alone with matched de novo nidus volume. Outcomes including incidences of favorable clinical outcome (obliteration without hemorrhage, cyst formation, worsening, or new seizures), obliteration, adverse effects, and angioarchitectural complexity were evaluated.RESULTS: The study cohort comprised 17 patients in the embolized group (median AVM volume 17.0 ml) and 35 patients in the nonembolized group (median AVM volume 13.1 ml). The rates of obliteration (embolized cohort: 33%, 44%, and 56%; nonembolized cohort: 32%, 47%, and 47% at 4, 6, and 10 years, respectively) and favorable outcome were comparable between the 2 groups. However, the embolized group had a significantly higher incidence of repeat SRS (41% vs 23%, p = 0.012) and total procedures (median number of procedures 4 vs 1, p < 0.001), even with a significantly higher margin dose delivered at the first SRS (23 Gy vs 17 Gy, p < 0.001). The median angioarchitectural complexity score was reduced from 7 to 5 after embolization. Collateral flow and neovascularization were more frequently observed in the embolized nonobliterated AVMs.CONCLUSIONS: Both embolization plus SRS and SRS alone were effective therapies for moderately large (8–39 ml) AVMs. Even with a significantly higher prescription dose at the time of initial SRS, the embolized group still required more procedures to reach final obliteration. The presence of collateral flow and neovascularization could be risk factors for a failure to obliterate following treatment.

1 August 2020 in Journal of Neurosurgery
Verified
Journal Article
Closed access
DCDiogo Cordeiro
Diogo Cordeiro
ZXZhiyuan Xu
Zhiyuan Xu
CLChelsea E. Li
Chelsea E. Li
CIChristian Iorio-Morin
Christian Iorio-Morin
DMDavid Mathieu
David Mathieu
JSJason Sheehan
Jason Sheehan
OBJECTIVE: Nelson’s syndrome is a rare and challenging neuroendocrine disorder, and it is associated with elevated adrenocorticotrophic hormone (ACTH) level, skin hyperpigmentation, and pituitary adenoma growth. Management options including resection and medical therapy are traditional approaches. Ionizing radiation in the form of Gamma Knife radiosurgery (GKRS) is also being utilized to treat Nelson’s syndrome. In the current study the authors sought to better define the therapeutic role of stereotactic radiosurgery (SRS) in Nelson’s syndrome.METHODS: Study patients with Nelson’s syndrome were treated with single-fraction GKRS (median margin dose of 25 Gy) at 6 different centers as part of an International Radiosurgery Research Foundation (IRRF) investigation. Data including neurological function, endocrine response, and radiological tumor response were collected and sent to the study-coordinating center for review. Fifty-one patients with median endocrine and radiological follow-ups of 91 and 80.5 months from GKRS, respectively, were analyzed for endocrine remission, tumor control, and neurological outcome. Statistical methods were used to identify prognostic factors for these endpoints.RESULTS: At last follow-up, radiological tumor control was achieved in 92.15% of patients. Endocrine remission off medical management and reduction in pre-SRS ACTH level were achieved in 29.4% and 62.7% of patients, respectively. Improved remission rates were associated with a shorter time interval between resection and GKRS (p = 0.039). Hypopituitarism was seen in 21.6% and new visual deficits were demonstrated in 15.7% of patients.CONCLUSIONS: GKRS affords a high rate of pituitary adenoma control and improvement in ACTH level for the majority of Nelson’s syndrome patients. Hypopituitarism is the most common adverse effect from GKRS in Nelson’s syndrome patients and warrants longitudinal follow-up for detection and endocrine replacement.

1 September 2019 in World Neurosurgery
Verified
Journal Article
Closed access
ASAdesh Shrivastava
Adesh Shrivastava
NMNasser Mohammed
Nasser Mohammed
YHYi-Chieh Hung
Yi-Chieh Hung
ZXZhiyuan Xu
Zhiyuan Xu
DSDavid Schlesinger
David Schlesinger
JSJason P. Sheehan
Jason P. Sheehan